Abstract

Introduction: Lipopolysaccharide (LPS) is a component of gram-negative bacteria, known for its ability to trigger inflammation. The main pathway of LPS clearance is the reverse lipopolysaccharide transport (RLT), with phospholipid transfer protein (PLTP) and lipoproteins playing central roles in this process in experimental animal models. To date, the relevance of this pathway has never been studied in humans. Cardiac surgery with cardiopulmonary bypass is known to favor LPS digestive translocation. Our objective was to determine whether pre-operative PLTP activity and triglyceride or cholesterol-rich lipoprotein concentrations were associated to LPS concentrations in patients undergoing cardiac surgery with cardiopulmonary bypass.Methods: A post-hoc analysis was conducted on plasma samples obtained from patients recruited in a randomized controlled trial.Total cholesterol, high density lipoprotein cholesterol (HDLc), low density lipoprotein cholesterol (LDLc), triglyceride and PLTP activity were measured before surgery. LPS concentration was measured by mass spectrometry before surgery, at the end of cardiopulmonary bypass and 24 h after admission to the intensive care unit.Results: High PLTP activity was associated with lower LPS concentration but not with inflammation nor post-operative complications. HDLc, LDLc and total cholesterol were not associated with LPS concentration but were lower in patients developing post-operative adverse events. HDLc was negatively associated with inflammation biomarkers (CRP, PCT). Triglyceride concentrations were positively correlated with LPS concentration, PCT and were higher in patients with post-operative complications.Conclusion: Our study supports the role of PLTP in LPS elimination and the relevance of RLT in human. PLTP activity, and not cholesterol rich lipoproteins pool size seemed to be the limiting factor for RLT. PLTP activity was not directly related to post-operative inflammation and adverse events, suggesting that LPS clearance is not the main driver of inflammation in our patients. However, HDLc was associated with lower inflammation and was associated with favorable outcomes, suggesting that HDL beneficial anti-inflammatory effects could be, at least in part independent of LPS clearance.

Highlights

  • Lipopolysaccharide (LPS) is a component of gram-negative bacteria, known for its ability to trigger inflammation

  • Regarding markers of gastrointestinal dysfunction, we found no association between phospholipid transfer protein (PLTP) activity, HDL cholesterol (HDLc) or total cholesterol with ALT, AST, intestinal fatty acid binding protein (I-FABP), or glucagon-like peptide-1 (GLP-1)

  • Pre-operative HDLc was not associated with LPS concentration but was negatively associated with post-operative inflammatory markers (CRP, PCT) and clinical outcome, suggesting those beneficial antiinflammatory effects to be independent of LPS clearance

Read more

Summary

Introduction

Lipopolysaccharide (LPS) is a component of gram-negative bacteria, known for its ability to trigger inflammation. Counteracting endotoxemia, the lipopolysaccharide reverse transport has been described by analogy with the reverse cholesterol transport [4] This pathway involves circulating lipoproteins which can bind and carry LPS to the liver where it is detoxified and eliminated through biliary secretion [4]. One key player in this process is the plasma phospholipid transfer protein (PLTP) which promotes the binding LPS to lipoproteins thereby reducing their capacity to activate inflammation [5]. This pathway modulates inflammation by preventing TLR4 activation

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call